Telomir Pharmaceuticals saw a rise in after-hours trading after announcing positive results for its Telmor-1 anti-aging treatment. Shares were up 4.7% at $4.40.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Telomir Pharmaceuticals saw a rise in after-hours trading after announcing positive results for its Telmor-1 anti-aging treatment. Shares were up 4.7% at $4.40.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.